NESS 0327 – 10 mg

Brand:
Cayman
CAS:
494844-07-4
Storage:
-20
UN-No:
Non-Hazardous - /

NESS 0327 is an extremely potent cannabinoid (CB) receptor antagonist with high selectivity for the CB1 receptor compared to the CB2 receptor with Ki values of 0.35 pM and 21 nM, respectively.{11553} It is a much more potent antagonist and more selective for the CB1 receptor compared to SR 141716A (rimonabant). At nM concentrations NESS 0327 competitively inhibits the binding of the synthetic CB agonist WIN 55,212-2 in isolated rat cerebella membranes and murine vas deferens.{11553,15795} Unlike SR 141716A, NESS 0327 at higher doses does not act as a CB1 receptor inverse agonist and does not produce any physiological effects of its own.{11553,15795}  

 

Available on backorder

SKU: 10004184 - 10 mg Category:

Description

An extremely potent cannabinoid receptor antagonist with high selectivity for the central CB1 receptor (Ki = 0.35 pM) compared to the peripheral CB2 receptor (Ki = 21 nM)


Formal name: 8-chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydro-N-1-piperidinyl-benzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide

Synonyms: 

Molecular weight: 489.8

CAS: 494844-07-4

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors